Incyte (INCY) EBITDA (2010 - 2026)

Incyte has reported EBITDA for 17 years, with the latest figure at $301.1 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 46.77% year-over-year to $301.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 822.38% YoY), and the FY2025 full-year result was $1.5 billion, up 2368.56% from the prior year.
• EBITDA for Q1 2026 stood at $301.1 million, down from $335.9 million in the prior quarter.
• The five-year high for EBITDA was $530.3 million in Q2 2025, with the low at -$478.1 million in Q2 2024.
• Historically, EBITDA has averaged $181.0 million across 5 years, with a median of $193.8 million in 2023.
• The largest YoY upside for EBITDA was 271.01% in 2024 against a maximum downside of 346.74% in 2024.
• Incyte's EBITDA stood at $70.1 million in 2022, then surged by 167.17% to $187.3 million in 2023, then surged by 61.0% to $301.5 million in 2024, then advanced by 11.39% to $335.9 million in 2025, then decreased by 10.34% to $301.1 million in 2026.
• The last three EBITDA figures came in at $301.1 million (Q1 2026), $335.9 million (Q4 2025), and $443.5 million (Q3 2025), per Business Quant data.